DA32 Life Science Tech Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DALS research report →
About the company
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies.
- CEO
- Steven Kafka
- IPO
- 2021
- HQ
- New York City, NY, US
Price Chart
- 52W High
- $11.22
- 52W Low
- $9.68
- 50D MA
- $10.27
- 200D MA
- $10.09
- Beta
- 0.00
- Avg Volume
- 29.06K
Get TickerSpark's AI analysis on DALS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 28, 23 | CRANDELL KEITH | other | 1,600,000 |
| Jul 28, 23 | ARCH Venture Fund XI, L.P. | other | 1,600,000 |
| Jul 28, 23 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | other | 1,600,000 |
| Aug 5, 21 | Section 32 Fund 3, LP | sell | 701,250 |
| Aug 5, 21 | Section 32 Fund 3, LP | sell | 30,000 |
| Aug 5, 21 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | sell | 701,250 |
| Aug 5, 21 | Wolfe Chris | sell | 18,750 |
| Aug 5, 21 | CRANDELL KEITH | sell | 701,250 |
| Aug 5, 21 | ARCH Venture Fund XI, L.P. | other | 701,250 |
| Aug 5, 21 | DA32 Sponsor LLC | other | 701,250 |
Our DALS coverage
Recent articles, reports, and earnings notes.
No research on DALS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DALS report →Similar companies
Peers in the same neighborhood.